TD Asset Management’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.2M | Sell |
|
|||||
|
2025
Q1 | $8.45M | Buy |
|
|||||
|
2024
Q4 | $4.72M | Buy |
|
|||||
|
2024
Q3 | $3.49M | Sell |
|
|||||
|
2024
Q2 | $3.63M | Buy |
|
|||||
|
2024
Q1 | $3.16M | Buy |
|
|||||
|
2023
Q4 | $2.2M | Sell |
|
|||||
|
2023
Q3 | $6.38M | Buy |
|
|||||
|
2023
Q2 | $2.93M | Buy |
|
|||||
|
2023
Q1 | $2.22M | Buy |
|
|||||
|
2022
Q4 | $2.87M | Buy |
|
|||||
|
2022
Q3 | $570K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $531K | Hold |
|
|||||
|
2021
Q3 | $561K | Hold |
|
|||||
|
2021
Q2 | $538K | Hold |
|
|||||
|
2021
Q1 | $728K | Buy |
|
|||||
|
2020
Q4 | $506K | Buy |
|
|||||
|
2020
Q3 | $480K | Buy |
|
|||||
|
2020
Q2 | $217K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $229K | Hold |
|
|||||
|
2019
Q3 | $235K | Buy |
|